Influences of APOA5 variants on plasma triglyceride levels in Uyghur population

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Li, Shuyuan ^a,b   Hu, Bin ^a,b   Wang, Yi ^a,b   Wu, Di ^a   Jin, Li ^a,b   Wang, Xiaofeng ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Fudan Taizhou Institute of Health Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A5; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A;

ADULT; ALLELE; APOA5 GENE; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EAST ASIAN; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; GENETIC ASSOCIATION; GENETICS; MIDDLE AGED;

ADULT; ALLELES; APOLIPOPROTEINS A; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 84908013299     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110258     Document Type: Article

References (36)

1. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, et al. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169-173.
2. van der Vliet HN, Schaap FG, Levels JH, Ottenhoff R, Looije N, et al. (2002) Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochem Biophys Res Commun 295: 1156-1159.
3. Merkel M, Heeren J (2005) Give me A5 for lipoprotein hydrolysis! J Clin Invest 115: 2694-2696.
4. van Dijk KW, Rensen PC, Voshol PJ, Havekes LM (2004) The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? Curr Opin Lipidol 15: 239-246.
5. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, et al. (2002) Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11: 3031-3038.
6. Lai CQ, Demissie S, Cupples LA, Zhu Y, Adiconis X, et al. (2004) Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res 45: 2096-2105.
7. Olivier M, Wang X, Cole R, Gau B, Kim J, et al. (2004) Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics 83: 912-923.
8. Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, et al. (2002) Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11: 3039-3046.
9. Aouizerat BE, Kulkarni M, Heilbron D, Drown D, Raskin S, et al. (2003) Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res 44: 1167-1173.
10. Lee KW, Ayyobi AF, Frohlich JJ, Hill JS (2004) APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease. Atherosclerosis 176: 165-172.
11. Li YY, Yin RX, Lai CQ, Li M, Long XJ, et al. (2011) Association of apolipoprotein A5 gene polymorphisms and serum lipid levels. Nutr Metab Cardiovasc Dis 21: 947-956.
12. Yin RX, Li YY, Lai CQ (2011) Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels. Lipids Health Dis 10: 140.
13. Lai CQ, Tai ES, Tan CE, Cutter J, Chew SK, et al. (2003) The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 44: 2365-2373.
14. Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B (2010) Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Atherosclerosis 208: 427-432.
15. Chien KL, Fang WH, Wen HC, Lin HP, Lin YL, et al. (2008) APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. Clin Chim Acta 390: 56-62.
16. Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW (2003) A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 12: 2533-2539.
17. Tang Y, Sun P, Guo D, Ferro A, Ji Y, et al. (2006) A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis 185: 433-437.
18. Matsunaga A, Arishima H, Niimura H, Zhang B, Uehara Y, et al. (2007) Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population. Circ J 71: 746-752.
19. Yamada Y, Ichihara S, Kato K, Yoshida T, Yokoi K, et al. (2008) Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people. J Med Genet 45: 22-28.
20. Yao YG, Kong QP, Wang CY, Zhu CL, Zhang YP (2004) Different matrilineal contributions to genetic structure of ethnic groups in the silk road region in china. Mol Biol Evol 21: 2265-2280.
21. Xu S, Huang W, Qian J, Jin L (2008) Analysis of genomic admixture in Uyghur and its implication in mapping strategy. Am J Hum Genet 82: 883-894.
22. Bacanu SA, Devlin B, Roeder K (2002) Association studies for quantitative traits in structured populations. Genet Epidemiol 22: 78-93.
23. Wang L, Tao Y, Xie Z, Ran X, Zhang M, et al. (2010) Prevalence of metabolic syndrome, insulin resistance, impaired fasting blood glucose, and dyslipidemia in Uygur and Kazak populations. J Clin Hypertens (Greenwich) 12: 741-745.
24. Lin R, Wang X, Wang Y, Zhang F, Wang Y, et al. (2009) Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations. Hum Mutat 30: 609-615.
25. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
26. Hodoglugil U, Tanyolac S, Williamson DW, Huang Y, Mahley RW (2006) Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks. J Lipid Res 47: 144-153.
27. Chandak GR, Ward KJ, Yajnik CS, Pandit AN, Bavdekar A, et al. (2006) Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans. BMC Med Genet 7: 76.
28. Wright WT, Young IS, Nicholls DP, Patterson C, Lyttle K, et al. (2006) SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population. Atherosclerosis 185: 353-360.
29. Lai CQ, Parnell LD, Ordovas JM (2005) The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk. Curr Opin Lipidol 16: 153-166.
30. Xu C, Bai R, Zhang D, Li Z, Zhu H, et al. (2013) Effects of APOA5 -1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysis. PLoS One 8: e56216.
31. Eichenbaum-Voline S, Olivier M, Jones EL, Naoumova RP, Jones B, et al. (2004) Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 24: 167-174.
32. Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, et al. (2007) The -1131 T> C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis 191: 409-417.
33. Wang J, Ban MR, Zou GY, Cao H, Lin T, et al. (2008) Polygenic determinants of severe hypertriglyceridemia. Hum Mol Genet 17: 2894-2899.
34. Talmud PJ, Martin S, Taskinen MR, Frick MH, Nieminen MS, et al. (2004) APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res 45: 750-756.
35. Caussy C, Charriere S, Marcais C, Di Filippo M, Sassolas A, et al. (2014) An APOA5 3′ UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site. Am J Hum Genet 94: 129-134.
36. Ishihara M, Kujiraoka T, Iwasaki T, Nagano M, Takano M, et al. (2005) A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. J Lipid Res 46: 2015-2022.